Clinical Study Proves Effectiveness of 4Life™ Products
Duane Townsend, M.D.   •   Gynecologic Oncologist

Objective: 

Our medical practice has been collecting data for the past year for a variety of gynecologic conditions to determine what 4Life™ products could do for our patients.  Each trial was observed for at least two months and most are ongoing.

Transfer Factor™ used with over 300 individuals.

Conditions:  Cancer, herpes, yeast, condyloma, arthritis, colds, sore throats, and lupus.

Ages: 2 - 80 years

Dose: maintenance - 3 TF daily
          Illness - triple daily dose

Results: all have noticed dramatic improvement [time response varied according to seriousness of condition (most serious - 4 weeks or more)] BioGenistein Plus™ and FemPro™  used by 81 women - ages: 42 - 75

 

Condition: Menopausal symptoms

Dose: usually one BioGenistein Plus™ and apply FemPro™ twice daily.

Results: 45 were asymptomatic

21 had mild hot flashes requiring some estrogen

15 required daily estrogen doses (time response varied)

 

Other gynecologic problems: 

ages: women 25 - 50 years
dose: usually one BioGenistein Plus™ and apply FemPro™ twice daily.

Results: 

7 women with fibroid tumors: in six, the tumors are shrinking (3 - 4 months time response) 35 women with PMS

Results: symptoms controlled in 33 women (4 week time response)

32 women with abnormal uterine bleeding

Results: 26 returned to normal (some had results immediately, others saw results by 4 - 6 weeks)

FibroAMJ™   57 patients, primarily women ages: 40 - 50

Conditions:  Fibromyalgia, arthritis, CFS.

dosage/protocol: Special diet, no soft drinks or chocolate, exercise, 8 TF, 3 FibroAMJ™ Day-time and 1 Night-time (if not on prescription sleep medication)

Results: 55 have had major improvement (4 - 6 weeks time response)

    * This data is preliminary

35 women with PMS

Results: symptoms controlled in 33 women (4 week time response)

32 women with abnormal uterine bleeding

Results: 26 returned to normal (some had results immediately, others saw results by 4 - 6 weeks)

FibroAMJ™   57 patients, primarily women ages: 40 - 50

Conditions:  Fibromyalgia, arthritis, CFS.

dosage/protocol: Special diet, no soft drinks or chocolate, exercise, 8 TF, 3 FibroAMJ™ Day-time and 1 Night-time (if not on prescription sleep medication)

Results: 55 have had major improvement (4 - 6 weeks time response)

    * This data is preliminary